Decitabine-primed tandem CD19/CD20 car T cells

Clinical trials for Decitabine-primed tandem CD19/CD20 car T cells explained in plain language.

Never miss a new study

Get alerted when new Decitabine-primed tandem CD19/CD20 car T cells trials appear

Sign up with your email to follow new studies for Decitabine-primed tandem CD19/CD20 car T cells, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Engineered immune cells primed with decitabine show promise for tough lymphoma

Disease control Ongoing

This early-phase trial is testing a new type of immunotherapy for people with B-cell Non-Hodgkin's lymphoma that has returned or not responded to treatment. The therapy uses a patient's own immune cells, which are modified in the lab to target two proteins (CD19 and CD20) on canc…

Matched conditions: DECITABINE-PRIMED TANDEM CD19/CD20 CAR T CELLS

Phase 1/2 • Sponsor: Han weidong • Aim: Disease control

Last updated Jun 26, 2026 19:07 UTC

Decitabine-primed tandem CD19/CD20 car T cells

Get alerted when new Decitabine-primed tandem CD19/CD20 car T cells trials appear

Engineered immune cells primed with decitabine show promise for tough lymphoma